Immunotherapy in Acute Myeloid Leukemia: Where We Stand

Immunotherapy in Acute Myeloid Leukemia: Where We Stand

In the past few years, our improved knowledge of acute myeloid leukemia (AML) pathogenesis has led to the accelerated discovery of new drugs and the development of innovative therapeutic approaches. The role of the immune system in AML development, growth and recurrence has gained increasing interes...

Full description

Bibliographic Details
Main Authors: Alessandro Isidori, Claudio Cerchione, Naval Daver, Courtney DiNardo, Guillermo Garcia-Manero, Marina Konopleva, Elias Jabbour, Farhad Ravandi, Tapan Kadia, Adolfo de la Fuente Burguera, Alessandra Romano, Federica Loscocco, Giuseppe Visani, Giovanni Martinelli, Hagop Kantarjian, Antonio Curti
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
acute myeloid leukemia
tolerance
natural killer
immunotherapy
monoclonal antibody
checkpoint inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.656218/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.656218/full

Similar Items